Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.

Chae, Young Kwang; Chiec, Lauren; Adney, Scott K; Waitzman, Josh; Costa, Ricardo; Carneiro, Benedito; Matsangou, Maria; Agulnik, Mark; Kopp, Peter; Giles, Frank

Chae, Young Kwang; Chiec, Lauren; Adney, Scott K; Waitzman, Josh; Costa, Ricardo; Carneiro, Benedito; Matsangou, Maria; Agulnik, Mark; Kopp, Peter; Giles, Frank.

Afiliação

Chae YK; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Chiec L; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
Adney SK; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Waitzman J; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Costa R; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Carneiro B; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Matsangou M; Lifespan Cancer Institute, Providence, RI 02906, USA.
Agulnik M; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Kopp P; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
Giles F; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Oncotarget ; 9(46): 28281-28289, 2018 Jun 15.

Article em En | MEDLINE | ID: mdl-29963277

Palavras-chave

lenvatinib; posterior reversible encephalopathy syndrome; takotsubo cardiomyopathy; thyroid cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google